Expression of multiple cancer-testis antigen genes in gastrointestinal and breast carcinomas

Article metrics

Abstract

Cancer-testis antigens (CTAs) such as MAGE are selectively expressed in various types of human neoplasms but not in normal tissues other than testis. This characteristic feature of CTAs makes them promising antigens for cancer-specific immunotherapy. A critical requirement for this therapy is identification of promising antigens. In this study, we investigated the expression of 6 genes recently identified by serological analysis of antigens by recombinant expression (SEREX) libraries: NY-ESO-1, LAGE-1, SCP-1, SSX-1, SSX-2, and SSX-4, in many surgical samples of gastrointestinal and breast carcinomas using reverse transcription-polymerase chain reaction. We found relatively high expression of SCP-1 (23.5%) and SSX-4 (20.6%) in gastric carcinoma, LAGE-1 (39.1%) and NY-ESO-1 (23.9%) in oesophageal carcinoma, and SCP-1 (34.1%) in breast carcinoma. We also found frequent synchronous expression with MAGE, including LAGE-1 (46.2%) in oesophageal carcinoma, SSX-4 (46.7%) in gastric carcinoma, and SCP-1 (38.3%) in breast carcinoma. Immunohistochemical analysis of the tumour samples expressing both MAGE-4 and NY-ESO-1 genes demonstrated differences in distribution between MAGE-4 and NY-ESO-1 in serial sections. We concluded that NY-ESO-1, LAGE-1, SCP-1 and SSX-4 genes may be promising candidates for cancer-specific immunotherapy in addition to MAGE, and that polyvalent cancer vaccines may be useful in cases of heterogeneous expressions of CTA genes in gastrointestinal and breast carcinomas. © 2001 Cancer Research Campaign www.bjcancer.com

Change history

  • 16 November 2011

    This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication

References

  1. Boel, P, Wildmann, C, Sensi, ML, Brasseur, R, Renauld, JC, Coulie, P, Boon, T & van der Bruggen, P (1995). BAGE: a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes. Immunity, 2, 167–175.

  2. Chaux, P, Vantomme, V, Stroobant, V, Thielemans, K, Corthals, J, Luiten, R, Eggermont, AM, Boon, T & van der Bruggen, P (1999). Identification of MAGE-3 epitopes presented by HLA-DR molecules to CD4(+) T lymphocytes. J Exp Med, 189, 767–778.

  3. Chen, YT, Gure, AO, Tsang, S, Stockert, E, Jager, E, Knuth, A & Old, LJ (1998). Identification of multiple cancer/testis antigens by allogeneic antibody screening of a melanoma cell line library. Proc Natl Acad Sci USA, 95, 6919–6923.

  4. Chen, YT, Scanlan, MJ, Sahin, U, Türeci, O, Gure, AO, Tsang, S, Williamson, B, Stockert, E, Pfreundschuh, M & Old, LJ (1997). A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. Proc Natl Acad Sci USA, 94, 1914–1918.

  5. Chomczynski, P & Sacchi, N (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem, 162, 156–159.

  6. Dignam, JJ (2000). Differences in breast cancer prognosis among African-American and Caucasian women. CA Cancer J Clin, 50, 50–64.

  7. Fujie, T, Mori, M, Ueo, H, Sugimachi, K & Akiyoshi, T (1997). Expression of MAGE and BAGE genes in Japanese breast cancers. Ann Oncol, 8, 369–372.

  8. Fujie, T, Tahara, K, Tanaka, F, Mori, M, Takesako, K & Akiyoshi, T (1999). A MAGE-1-encoded HLA-A24-binding synthetic peptide induces specific anti-tumor cytotoxic T lymphocytes. Int J Cancer, 80, 169–172.

  9. Greenlee, RT, Murray, T, Bolden, S & Wingo, PA (2000). Cancer statistics, 2000. CA Cancer J Clin, 50, 7–33.

  10. Gure, AO, Türeci, O, Sahin, U, Tsang, S, Scanlan, MJ, Jager, E, Knuth, A, Pfreundschuh, M, Old, LJ & Chen, YT (1997). SSX: a multigene family with several members transcribed in normal testis and human cancer. Int J Cancer, 72, 965–971.

  11. Inoue, H, Mori, M, Honda, M, Li, J, Shibuta, K, Mimori, K, Ueo, H & Akiyoshi, T (1995). The expression of tumor-rejection antigen ‘MAGE’ genes in human gastric carcinoma. Gastroenterology, 109, 1522–1525.

  12. Inoue, K, Ozeki, Y, Suganuma, T & Sugiura, Y Tanaka, S (1997). Vascular endothelial growth factor expression in primary esophageal squamous cell carcinoma. Association with angiogenesis and tumor progression. Cancer, 79, 206–213.

  13. Jungbluth, AA, Stockert, E, Chen, YT, Kolb, D, Iversen, K, Coplan, K, Williamson, B, Altorki, N, Busam, KJ & Old, LJ (2000). Monoclonal antibody MA454 reveals a heterogeneous expression pattern of MAGE-1 antigen in formalin-fixed paraffin embedded lung tumours. Br J Cancer, 83, 493–497.

  14. Kocher, T, Schultz, TE, Gudat, F, Schaefer, C, Casorati, G, Juretic, A, Willimann, T, Harder, F, Heberer, M & Spagnoli, GC (1995). Identification and intracellular location of MAGE-3 gene product. Cancer Res, 55, 2236–2239.

  15. Landry, C, Brasseur, F, Spagnoli, GC, Marbaix, E, Boon, T, Coulie, P & Godelaine, D (2000). Monoclonal antibody 57B stains tumor tissues that express gene MAGE-A4. Int J Cancer, 86, 835–841.

  16. Lethe, B, Lucas, S, Michaux, L, De, SC, Godelaine, D, Serrano, A, De, PE & Boon, T (1998). LAGE-1, a new gene with tumor specificity. Int J Cancer, 76, 903–908.

  17. Manici, S, Sturniolo, T, Imro, MA, Hammer, J, Sinigaglia, F, Noppen, C, Spagnoli, G, Mazzi, B, Bellone, M, Dellabona, P & Protti, MP (1999). Melanoma cells present a MAGE-3 epitope to CD4(+) cytotoxic T cells in association with histocompatibility leukocyte antigen DR11. J Exp Med, 189, 871–876.

  18. Marchand, M, Weynants, P, Rankin, E, Arienti, F, Belli, F, Parmiani, G, Cascinelli, N, Bourlond, A, Vanwijck, R, Humblet, Y, Canon, J-L, Laurent, C, Naeyaert, J-M, Plagne, R, Deraemaeker, R, Knuth, A, Jager, E, Brasseur, F, Herman, J, Coulie, PG & Boon, T (1995). Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGE-3. Int J Cancer, 63, 883–885.

  19. Mori, M, Inoue, H, Mimori, K, Shibuta, K, Baba, K, Nakashima, H, Haraguchi, M, Tsuji, K, Ueo, H, Barnard, GF & Akiyoshi, T (1996). Expression of MAGE genes in human colorectal carcinoma. Ann Surg, 224, 183–188.

  20. Mukherji, B, Chakraborty, NG, Yamasaki, S, Okino, T, Yamase, H, Sporn, JR, Kurtzman, SK, Ergin, MT, Ozols, J, Meehan, J & Murai, F (1995). Induction of antigen-specific cytolytic T cells in situ in human melanoma by immunization with synthetic peptide-pulsed autologous antigen presenting cells. Proc Natl Acad Sci USA, 92, 8078–8082.

  21. Ries, LA, Wingo, PA, Miller, DS, Howe, HL, Weir, HK, Rosenberg, HM, Vernon, SW, Cronin, K & Edwards, BK (2000). The annual report to the nation on the status of cancer, 1973–1997, with a special section on colorectal cancer. Cancer, 88, 2398–2424.

  22. Sadanaga, N, Nagashima, H, Tahara, K, Yoshikawa, Y & Mori, M (1999). The heterogeneous expression of MAGE-3 protein: difference between primary lesions and metastatic lymph nodes in gastric carcinoma. Oncol Rep, 6, 975–977.

  23. Sahin, U, Türeci, O, Schmitt, H, Cochlovius, B, Johannes, T, Schmits, R, Stenner, F, Luo, G, Schobert, I & Pfreundschuh, M (1995). Human neoplasms elicit multiple specific immune responses in the autologous host. Proc Natl Acad Sci USA, 92, 11810–11813.

  24. Schultz, TE, Noppen, C, Gudat, F, Durmuller, U, Zajac, P, Kocher, T, Heberer, M & Spagnoli, GC (2000). NY-ESO-1 tumour associated antigen is a cytoplasmic protein detectable by specific monoclonal antibodies in cell lines and clinical specimens. Br J Cancer, 83, 204–208.

  25. Tahara, K, Mori, M, Sadanaga, N, Sakamoto, Y, Kitano, S & Makuuchi, M (1999). Expression of the MAGE gene family in human hepatocellular carcinoma. Cancer, 85, 1234–1240.

  26. Tanaka, F, Fujie, T, Tahara, K, Mori, M, Takesako, K, Sette, A, Celis, E & Akiyoshi, T (1997). Induction of antitumor cytotoxic T lymphocytes with a MAGE-3-encoded synthetic peptide presented by human leukocytes antigen-A24. Cancer Res, 57, 4465–4468.

  27. Tokunaga, K, Nakamura, Y, Sakata, K, Fujimori, K, Ohkubo, M, Sawada, K & Sakiyama, S (1987). Enhanced expression of a glyceraldehyde-3-phosphate dehydrogenase gene in human lung cancers. Cancer Res, 47, 5616–5619.

  28. Türeci, O, Chen, YT, Sahin, U, Gure, AO, Zwick, C, Villena, C, Tsang, S, Seitz, G, Old, LJ & Pfreundschuh, M (1998a). Expression of SSX genes in human tumors. Int J Cancer, 77, 19–23.

  29. Türeci, O, Sahin, U, Schobert, I, Koslowski, M, Scmitt, H, Schild, HJ, Stenner, F, Seitz, G, Rammensee, HG & Pfreundschuh, M (1996). The SSX-2 gene, which is involved in the t(X;18) translocation of synovial sarcomas, codes for the human tumor antigen HOM-MEL-40. Cancer Res, 56, 4766–4772.

  30. Türeci, O, Sahin, U, Zwick, C, Koslowski, M, Seitz, G & Pfreundschuh, M (1998b). Identification of a meiosis-specific protein as a member of the class of cancer/testis antigens. Proc Natl Acad Sci USA, 95, 5211–5216.

  31. Van den Eynde, B, Peeters, O, De, BO, Gaugler, B, Lucas, S & Boon, T (1995). A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma. J Exp Med, 182, 689–698.

  32. Van den Eynde, B & Boon, T (1997). Tumor antigens recognized by T lymphocytes. Int J Clin Lab Res, 27, 81–86.

  33. Van der Bruggen, P, Traversari, C, Chomez, P, Lurquin, C, De, PE, Van den Eynde, B, Knuth, A & Boon, T (1991). A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science, 254, 1643–1647.

  34. Weynants, P, Lethe, B, Brasseur, F, Marchand, M & Boon, T (1994). Expression of mage genes by non-small-cell lung carcinomas. Int J Cancer, 56, 826–829.

Download references

Author information

Rights and permissions

From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/

Reprints and Permissions

About this article

Cite this article

Mashino, K., Sadanaga, N., Tanaka, F. et al. Expression of multiple cancer-testis antigen genes in gastrointestinal and breast carcinomas. Br J Cancer 85, 713–720 (2001) doi:10.1054/bjoc.2001.1974

Download citation

Keywords

  • MAGE tumour-rejection antigens, cancer-testis antigen, immunotherapy, cancer vaccine

Further reading